On Tuesday, Palisade Bio Inc (NASDAQ: PALI) was 6.07% up from the session before settling in for the closing price of $0.79. A 52-week range for PALI has been $0.60 – $8.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -40.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 82.17%. With a float of $4.36 million, this company’s outstanding shares have now reached $4.40 million.
The firm has a total of 8 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Palisade Bio Inc (PALI) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Palisade Bio Inc stocks. The insider ownership of Palisade Bio Inc is 0.81%, while institutional ownership is 4.53%. The most recent insider transaction that took place on May 28 ’24, was worth 4,863. In this transaction Director of this company bought 1,000 shares at a rate of $4.86, taking the stock ownership to the 1,000 shares. Before that another transaction happened on May 24 ’24, when Company’s CEO, CFO, Director bought 1,000 for $4.81, making the entire transaction worth $4,810. This insider now owns 8,437 shares in total.
Palisade Bio Inc (PALI) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 82.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 53.17% during the next five years compared to 77.35% growth over the previous five years of trading.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
You can see what Palisade Bio Inc (PALI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -13.03, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -1.05 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Analysing the last 5-days average volume posted by the [Palisade Bio Inc, PALI], we can find that recorded value of 0.27 million was lower than the volume posted last year of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 80.97%. Additionally, its Average True Range was 0.07.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 8.70%, which indicates a significant decrease from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.36% in the past 14 days, which was lower than the 130.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7689, while its 200-day Moving Average is $2.2319. Now, the first resistance to watch is $0.8941. This is followed by the second major resistance level at $0.9533. The third major resistance level sits at $1.0719. If the price goes on to break the first support level at $0.7163, it is likely to go to the next support level at $0.5977. Now, if the price goes above the second support level, the third support stands at $0.5385.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
There are 4,397K outstanding shares of the company, which has a market capitalization of 3.67 million. As of now, sales total 0 K while income totals -14,440 K. Its latest quarter income was 0 K while its last quarter net income were -3,340 K.
